Indonesia: CDAKB (GDP) certificate required for product registration

In brief

On 11 May 2024, the Ministry of Health (MOH) issued circular letter No. FR.03.01/E/884/2024 ("Letter"). In the Letter, the MOH announced that a Good Distribution Practice for Medical Devices (Cara Distribusi Alat Kesehatan Yang Baik or CDAKB) certificate will be required as a pre-requisite for the issuance of the product registration (izin edar).


Previous position

Medical device wholesalers are generally required to implement and comply with CDAKB guidelines set out by the MOH) as part of their business licensing commitment. 

Up to now, the MOH does not require wholesalers to hold a CDAKB certificate before they can apply for and obtain product registrations for medical device products. Based on the Letter, starting from 1 July 2024, a CDAKB certificate will be required. The following prevailing regulations are silent on this matter, and do not expressly specify that a CDAKB certificate is one of the required documents for medical device wholesalers to obtain product registrations: 

  1. MOH Regulation No. 62 of 2017 on Product Registration of Medical Devices In Vitro Diagnostic and Household Medical Supplies ("MOH Regulation 62").
  2. MOH Regulation No. 14 of 2021 on Standard of Risk Based Licensing in the Healthcare Sector ("MOH Regulation 14").

Key takeaways 

Pursuant to the Letter, the MOH will implement its new policy in stages: 

  1. MOH will circulate socializations on the implementation of its new policy for CDAKB between 1 May 2024 and 30 June 2024 through its online platform (i.e., 'regalkes'). 
  2. MOH will implement the new policy and require wholesalers to obtain CDAKB certificate as pre-requisite for obtaining product registration starting 1 July 2024. 

(Any information regarding CDAKB certificate application may be accessed through the following link: sertifikasialkes.kemkes.go.id)).

Our takeaways

  • It remains to be seen how the MOH will implement the Letter in the future (after 1 July 2024) against issued product registrations of non-CDAKB certificated medical device wholesalers. 
  • It is unclear whether the Letter would also mean that medical device wholesalers would be required to obtain a CDAKB certificate before they commence any commercial operation, regardless of whether or not they intend to apply for and obtain product registration.

Conclusion

Business actors that are planning to either invest in or set up a new medical device wholesaler company should consider this new development and factor the process of obtaining a CDAKB certificate into their timeline (especially when they plan to have the medical device wholesaler company become the holder of product registrations). 

Existing non-CDAKB certificated medical device wholesalers that also serve as product registration holders need to carefully monitor this progress and consult with the MOH closely to confirm (i) whether the MOH will adopt any grandfathering treatment for them, and (ii) what rectification or interim model they should adopt to comply with the MOH's new policy.

* * * * *

LOGO_Indonesia HHP Law Firm_Jakarta

© 2024 HHP Law Firm. All rights reserved. HHP Law Firm is a member firm of Baker & McKenzie International. This may qualify as "Attorney Advertising" requiring notice in some jurisdictions. Prior results do not guarantee a similar outcome.

Contact Information

Copyright © 2024 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.